Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

Treatments and trials you qualify for
Education for your stage of care
Financial support for your medications
Solutions to your side effects

Learn more about HealthTree

Video

How do you distinguish between a diagnosis of MDS and AML?

Posted by

HealthTree

• August 9, 2022

Description

Learn about how to distinguish a diagnosis of MDS and AML in this HealthTree University lesson by a cancer specialist.

On this video

Srinivasa Sanikommu, MD, Specialist

Levine Cancer Institute

Transcript

How do you distinguish between a diagnosis of MDS and AML? It is based on the bone marrow biopsy. And if patient has, you know, it's very arbitrary. 20% blast is considered as MDS. If they have more than 20% blast, it is leukemia. If they have less than 20%, you know, then it is MDS. So it's a continuous spectrum of disease, especially the high-risk MDS. You know, like 10 to 19% blast is MDS, but more than 20% is leukemia. So that is the current WHO, based on the current WHO classification.

Related Content